https://t.co/wKqR1oqKVU Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia
Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2022 – Nov 2022Where it's discussed
-
X / Twitter4 posts
-
Facebook2 posts
-
Reddit2 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions show strong interest through mentions like 'measuring the quality of care' and acknowledgment of the publication's importance in identifying gaps. Words such as 'significant' and references to 'standardized care' reflect concern about the current gaps in services and the potential for policy changes, suggesting a moderate level of engagement and recognition of the publication's impact.
Most discussions acknowledge the importance of the audit and support the need for improved IBD care quality, showing general agreement with the publication's focus.
The posts demonstrate high interest, as they highlight the significance of the findings and express curiosity about the implications for healthcare improvements.
While some posts mention the publication's details and suggest considering improvements, the overall depth of discussion remains moderate, with limited detailed analysis.
Participants recognize that the audit's findings could influence healthcare policies, but specific calls to action or concrete impacts are not strongly emphasized.
Abstract in brief
- Australia has one of the highest rates of Crohn's disease and ulcerative colitis in the world, leading to significant societal costs due to inconsistent care across the country.
- The audit found that most hospitals lack comprehensive multidisciplinary IBD services, with only one hospital having a full service, and care quality varies widely, showing gaps in documentation and adherence to national standards.
- Hospitals with partial IBD services generally performed better in key areas such as reducing emergency admissions and monitoring treatments, but overall, patients with IBD tend to be young, chronically ill, and experience frequent readmissions, highlighting the need for improved standardized care.
Top posts
Most liked on X and BlueskyThe Crohn’s & Colitis Australia Inflammatory Bowel Disease Audit: Measuring the quality of care in Australia. Monique Kilkenny et al. published in the Internal Medicine Journal https://t.co/wKqR1oqKVU
RT @UWA_SAH: The Crohn’s & Colitis Australia Inflammatory Bowel Disease Audit: Measuring the quality of care in Australia. Monique Kilkenny…
RT @UWA_SAH: https://t.co/wKqR1oqKVU Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Austral…
All mentions
Prevalence of Polypharmacy in Older Australians (2006-2017)
This video explores the prevalence of polypharmacy among Australians aged 70 and older from 2006 to 2017. Notably, in 2017, 36.1% of this demographic experienced continuous polypharmacy, indicating significant health…
RT @UWA_SAH: The Crohn’s & Colitis Australia Inflammatory Bowel Disease Audit: Measuring the quality of care in Australia. Monique Kilkenny…
RT @UWA_SAH: https://t.co/wKqR1oqKVU Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Austral…
https://t.co/wKqR1oqKVU Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia
The Crohn’s & Colitis Australia Inflammatory Bowel Disease Audit: Measuring the quality of care in Australia. Monique Kilkenny et al. published in the Internal Medicine Journal https://t.co/wKqR1oqKVU
US
C